312 related articles for article (PubMed ID: 26062758)
41. Newborn screening for metabolic disorders.
Marsden D; Larson C; Levy HL
J Pediatr; 2006 May; 148(5):577-584. PubMed ID: 16737864
[No Abstract] [Full Text] [Related]
42. Selective newborn screening of inborn errors of amino acids, organic acids and fatty acids metabolism in the Kingdom of Bahrain.
Golbahar J; Al-Jishi EA; Altayab DD; Carreon E; Bakhiet M; Alkhayyat H
Mol Genet Metab; 2013; 110(1-2):98-101. PubMed ID: 23916421
[TBL] [Abstract][Full Text] [Related]
43. [Neonatal screening for congenital errors of metabolism by means of Tandem Mass: Italian experience].
Cerone R; Cassanello M; Caruso U; Schiaffino MC; Lorini R
Minerva Pediatr; 2007 Oct; 59(5):488-9. PubMed ID: 17947884
[No Abstract] [Full Text] [Related]
44. The first pilot study of expanded newborn screening for inborn errors of metabolism and survey of related knowledge and opinions of health care professionals in Hong Kong.
Mak CM; Law EC; Lee HH; Siu WK; Chow KM; Au Yeung SK; Ngan HY; Tse NK; Kwong NS; Chan GC; Lee KW; Chan WP; Wong SF; Tang MH; Kan AS; Hui AP; So PL; Shek CC; Lee RS; Wong KY; Yau EK; Poon KH; Siu S; Poon GW; Kwok AM; Ng JW; Yim VC; Ma GG; Chu CH; Tong TY; Chong YK; Chen SP; Ching CK; Chan AO; Tam S; Lau RL; Ng WF; Lee KC; Chan AY; Lam CW
Hong Kong Med J; 2018 Jun; 24(3):226-237. PubMed ID: 29888706
[TBL] [Abstract][Full Text] [Related]
45. Pilot study of newborn screening of inborn error of metabolism using tandem mass spectrometry in Malaysia: outcome and challenges.
Yunus ZM; Rahman SA; Choy YS; Keng WT; Ngu LH
J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1031-9. PubMed ID: 27544719
[TBL] [Abstract][Full Text] [Related]
46. Four years of expanded newborn screening in Portugal with tandem mass spectrometry.
Vilarinho L; Rocha H; Sousa C; Marcão A; Fonseca H; Bogas M; Osório RV
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S133-8. PubMed ID: 20177789
[TBL] [Abstract][Full Text] [Related]
47. Screening for inborn errors of metabolism using automated electrospray tandem mass spectrometry: study in high-risk Indian population.
Nagaraja D; Mamatha SN; De T; Christopher R
Clin Biochem; 2010 Apr; 43(6):581-8. PubMed ID: 20026021
[TBL] [Abstract][Full Text] [Related]
48. Cost-effectiveness of expanded newborn screening in Texas.
Tiwana SK; Rascati KL; Park H
Value Health; 2012; 15(5):613-21. PubMed ID: 22867769
[TBL] [Abstract][Full Text] [Related]
49. Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry.
Tran K; Banerjee S; Li H; Noorani HZ; Mensinkai S; Dooley K
Clin Biochem; 2007 Feb; 40(3-4):235-41. PubMed ID: 17222812
[TBL] [Abstract][Full Text] [Related]
50. Tandem mass spectrometry in the detection of inborn errors of metabolism for newborn screening.
Turecek F; Scott CR; Gelb MH
Methods Mol Biol; 2007; 359():143-57. PubMed ID: 17484116
[TBL] [Abstract][Full Text] [Related]
51. Newborn screening of inherited metabolic disorders: the Italian situation.
Focardi M; Pinchi V; Defraia B; Gualco B; Varvara G; Norelli GA
J Biol Regul Homeost Agents; 2016; 30(3):909-914. PubMed ID: 27655520
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West Germany.
Lindner M; Gramer G; Haege G; Fang-Hoffmann J; Schwab KO; Tacke U; Trefz FK; Mengel E; Wendel U; Leichsenring M; Burgard P; Hoffmann GF
Orphanet J Rare Dis; 2011 Jun; 6():44. PubMed ID: 21689452
[TBL] [Abstract][Full Text] [Related]
53. Detection of other inborn errors of metabolism in hyperphenylalaninemic babies picked up on narrow-spectrum screening programs.
Unal O; Oztürk-Hişmi B; Coşkun T; Tokatlı A; Dursun A; Sivri HS
Turk J Pediatr; 2012; 54(4):409-12. PubMed ID: 23692723
[TBL] [Abstract][Full Text] [Related]
54. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years.
Wilcken B; Haas M; Joy P; Wiley V; Bowling F; Carpenter K; Christodoulou J; Cowley D; Ellaway C; Fletcher J; Kirk EP; Lewis B; McGill J; Peters H; Pitt J; Ranieri E; Yaplito-Lee J; Boneh A
Pediatrics; 2009 Aug; 124(2):e241-8. PubMed ID: 19620191
[TBL] [Abstract][Full Text] [Related]
55. [Diagnosis of inborn errors of metabolism: necessity or luxury?].
Stöckler S
Wien Klin Wochenschr; 1992; 104(16):493-6. PubMed ID: 1413806
[No Abstract] [Full Text] [Related]
56. Newborn screening: After the thrill is gone.
Vockley J
Mol Genet Metab; 2007; 92(1-2):6-12. PubMed ID: 17604202
[TBL] [Abstract][Full Text] [Related]
57. Application of mass spectrometry in newborn screening: about both small molecular diseases and lysosomal storage diseases.
Hwu WL; Chien YH; Lee NC; Wang SF; Chiang SC; Hsu LW
Top Curr Chem; 2014; 336():177-96. PubMed ID: 22911488
[TBL] [Abstract][Full Text] [Related]
58. Comprehensive cost-utility analysis of newborn screening strategies.
Carroll AE; Downs SM
Pediatrics; 2006 May; 117(5 Pt 2):S287-95. PubMed ID: 16735255
[TBL] [Abstract][Full Text] [Related]
59. Clinical characteristics of neonates with inborn errors of metabolism detected by Tandem MS analysis in Oman.
Joshi SN; Venugopalan P
Brain Dev; 2007 Oct; 29(9):543-6. PubMed ID: 17314022
[TBL] [Abstract][Full Text] [Related]
60. Cost effectiveness of establishing a neonatal screening programme for phenylketonuria in Libya.
Sladkevicius E; Pollitt RJ; Mgadmi A; Guest JF
Appl Health Econ Health Policy; 2010; 8(6):407-20. PubMed ID: 21043542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
